Angiogenesis assessment in patients with mycosis fungoides;Ocena angiogenezy u chorych na ziarniniaka grzybiastego

Postepy Dermatologii i Alergologii

Volumn 26, Issue 4, 2009, Pages 186-189

  Jankowska Konsur, Alina ^a   Maj, Joanna ^a   Woźniak, Zdzisław ^b   Baran, Eugeniusz ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b Katedra I Zaklad Anatomii Patologicznej Akademii Medycznej Im Piastow Slaskich we Wroclawiu   (United States)

Author keywords

Angiogenesis; Mycosis fungoides; Parapsoriasis en grandes plaques

Indexed keywords

BIOLOGICAL MARKER; CD34 ANTIGEN; MONOCLONAL ANTIBODY;

ANGIOGENESIS; ANTIGEN EXPRESSION; ARTICLE; CANCER STAGING; CONTROLLED STUDY; CUTANEOUS T CELL LYMPHOMA; DENSITY; ERYTHEMA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MICROVASCULATURE; MYCOSIS FUNGOIDES; PARAPSORIASIS; PROGNOSIS; SKIN BIOPSY;

EID: 70449623194     PISSN: 1642395X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Elmer KB, George RM. Cutaneous T-cell lymphoma presenting as benign dermatoses. Am Fam Phisician 1999; 59: 2809-2813 (Pubitemid 29239264)
2. Belousova IE, Vanecek T, Samtsov AV, et al. A patient with clinicopathological features of small plaque parapsoriasis presenting later as plaque-stage mycosis fungoides: report of a case and comparative study of 27 of "nonprogressive" small plaque parapsoriasis. J Am Acad Dermatol 2008; 59: 474-482
3. Reddy K, Bhawan J. Histologic mimickers of mycosis fungoides: a review. J Cutan Pathol 2007; 34: 519-525 (Pubitemid 46920261)
4. Olsen E, Vonderheid E, Pimpinelli N, et al. Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC). Blood 2007; 110: 1713-1722 (Pubitemid 47443880)
5. Guinebretiere JM. Angiogenesis and breast neoplasms. The pathologist's point of view. Gynecol Obstet Fertil 2005; 33: 140-146
6. Uzzan B, Nicholas P, Cucherat M, Perret GY. Microvessel density as a prognostic factor In women with breast cancer: a systematic review of the literature and meta-analysis. Cancer Res 2004; 64: 2941-2955 (Pubitemid 38581387)
7. Murri AM, Hilmy M, Bell J, et al. The relationship between the systemic inflammatory response, tumour proliferative activity, T-lymphocytic and macrophage infiltration, microvessel density and survival in patients with primary operable breast cancer. Br J Cancer 2008; 99: 1013-1019
8. Popiela TJ, Sikora J, Klimek M, et al. The analysis of CD34 immunoreactivity level in invasive ductal breast cancer with respect to the presence of lymph node metastases. Neuro Endocrinol Lett 2008; 29: 443-446
9. Koster A, Raemaekers JM. Angiogenesis in malignant lymphomas. Curr Opin Oncol 2005; 17: 611-616
10. Mazur G, Woźniak Z, Wróbel T, et al. Increased angiogenesis in cutaneous T-cell lymphomas. Pathol Oncol Res 2004; 10: 34-36 (Pubitemid 38506610)
11. Vacca A, Moretti S, Ribatti D, et al. Progression of mycosis fungoides is associated with changes in angiogenesis and expression of matrix metalloproteinases 2 and 9. Eur J Cancer 1997; 33: 1685-1692 (Pubitemid 28123494)
12. Baluk P, McDonald DM. Markers of microscoping imaging of lymphangiogenesis and angiogenesis. Ann N Y Acad Sci 2008; 1131: 1-12. (Pubitemid 351758499)
13. Nico B, Benagiano V, Mangieri D, et al. Evaluation of microvascular density in tumours: pro and contra. Histol Histopathol 2008; 23: 601-607 (Pubitemid 351559267)
14. Norrby K, Ridell G. Tumour-type-specific capillary endothelial cell stainability in malignant B-cell lymphomas using antibodies against CD31, CD34 and Factor VIII. APMIS 2003; 111: 483-489 (Pubitemid 36735007)
15. Sasano H, Suzuki T. Pathological analysis of angiogenesis in human tumors. Biomed Pharmacother 2005; 59 (Suppl 2): 334-336 (Pubitemid 43303899)